Sonnet BioTherapeutics, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • Overview
    • Platform
    • Strategy
    • Progress
    • Publications
  • Pipeline
    • Overview
    • Clinical Trials
  • Partnering
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Presentations
  • Events
Sep 20, 2023 7:30am EDT

Sonnet BioTherapeutics Announces Results of Biodistribution Studies Demonstrating Solid Tumor Targeting Using the FHAB Technology

Sep 19, 2023 8:30am EDT

Sonnet BioTherapeutics Regains Nasdaq Minimum Bid Price Compliance

Aug 31, 2023 10:55am EDT

Sonnet BioTherapeutics Announces 1-for-22 Reverse Stock Split

Aug 16, 2023 7:30am EDT

Sonnet BioTherapeutics Announces FDA Acceptance of the Company's IND for the SB221 Clinical Trial of SON-1010 Combined with Atezolizumab in the US

Aug 14, 2023 8:00am EDT

Sonnet BioTherapeutics Provides Fiscal Year 2023 Third Quarter Business and Earnings Update

Jul 31, 2023 9:00am EDT

Sonnet BioTherapeutics to Present at the 2023 BTIG Virtual Biotechnology Conference

Jun 28, 2023 8:00am EDT

Sonnet BioTherapeutics Announces $2.25 Million Registered Direct Offering and Concurrent Private Placement

Jun 23, 2023 8:00am EDT

Sonnet BioTherapeutics Announces Presentations at the 2023 Cytokine-Based Drug Development Summit and Provides Preliminary Update on the SON-080 Study in Chemotherapy-Induced Peripheral Neuropathy

Jun 20, 2023 8:00am EDT

Sonnet BioTherapeutics Announces Regulatory Approval for Initiation of a Clinical Trial of SON-1010 Combined with Atezolizumab

May 10, 2023 7:30am EDT

Sonnet BioTherapeutics Provides Fiscal Year 2023 Second Quarter and Year-to-Date Business and Earnings Update

RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Next
© 2023 Sonnet BioTherapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap